Toronto Dominion Bank’s Aimei Health Technology Co Right AFJKR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$192K Sell
622,219
-269,510
-30% -$100K ﹤0.01% 1580
2025
Q4
$334K Sell
891,729
-632,796
-42% -$239K ﹤0.01% 1418
2025
Q3
$488K Sell
1,524,525
-623,025
-29% -$224K ﹤0.01% 1282
2025
Q2
$515K Buy
2,147,550
+550,406
+34% +$140K ﹤0.01% 1180
2025
Q1
$575K Buy
1,597,144
+42,744
+3% +$11K ﹤0.01% 1144
2024
Q4
$13.2K Buy
+1,554,400
New +$338K ﹤0.01% 1445

Other funds holding AFJKR

Toronto Dominion Bank's AFJKR Position: Q1 2026 in Review

Toronto Dominion Bank reduced its Aimei Health Technology Co Right (AFJKR) stake by 30% in Q1 2026, selling an estimated $100K and leaving 622,219 shares worth $192K. The position accounts for ﹤0.01% of the portfolio, ranked #1580.

Toronto Dominion Bank first reported a position in AFJKR in Q4 2024 and has held it in 6 quarters since. The position peaked at $575K in Q1 2025. 15 funds tracked by Wall St. Rank hold AFJKR as of Q1 2026.

  • Toronto Dominion Bank held 622,219 shares of Aimei Health Technology Co Right worth $192K as of Q1 2026.
  • Toronto Dominion Bank sold 269,510 Aimei Health Technology Co Right shares in Q1 2026, an estimated $100K.
  • Aimei Health Technology Co Right made up ﹤0.01% of Toronto Dominion Bank's portfolio in Q1 2026, its #1580 holding.
  • Toronto Dominion Bank first reported a position in Aimei Health Technology Co Right in Q4 2024 and has held it in 6 quarters since.
  • Toronto Dominion Bank's Aimei Health Technology Co Right position peaked at $575K in Q1 2025.
  • 15 funds tracked by Wall St. Rank held Aimei Health Technology Co Right as of Q1 2026.

Based on Toronto Dominion Bank's 13F filing for Q1 2026, filed 15 May 2026.